Search Results
You are looking at 1 - 10 of 10 items for
- Author: Tao Zhang x
- Refine by access: All content x
Search for other papers by Zhenhua Li in
Google Scholar
PubMed
Search for other papers by Tao Zhang in
Google Scholar
PubMed
Search for other papers by Hongyan Dai in
Google Scholar
PubMed
Search for other papers by Guanghui Liu in
Google Scholar
PubMed
Search for other papers by Haibin Wang in
Google Scholar
PubMed
Search for other papers by Yingying Sun in
Google Scholar
PubMed
Search for other papers by Yun Zhang in
Google Scholar
PubMed
Search for other papers by Zhiming Ge in
Google Scholar
PubMed
Search for other papers by Zhenhua Li in
Google Scholar
PubMed
Search for other papers by Tao Zhang in
Google Scholar
PubMed
Search for other papers by Hongyan Dai in
Google Scholar
PubMed
Search for other papers by Guanghui Liu in
Google Scholar
PubMed
Search for other papers by Haibin Wang in
Google Scholar
PubMed
Search for other papers by Yingying Sun in
Google Scholar
PubMed
Search for other papers by Yun Zhang in
Google Scholar
PubMed
Search for other papers by Zhiming Ge in
Google Scholar
PubMed
Apoptosis plays a critical role in the diabetic cardiomyopathy, and endoplasmic reticulum stress (ERS) is one of the intrinsic apoptosis pathways. Previous studies have shown that the endoplasmic reticulum becomes swollen and dilated in diabetic myocardium, and ERS is involved in heart failure and diabetic kidney. This study is aimed to demonstrate whether ERS is induced in myocardium of streptozotocin (STZ)-induced diabetic rats. We established a type 1 diabetic rat model, used echocardiographic evaluation, hematoxylin–eosin staining, and the terminal deoxynucleotidyl transferase-mediated DNA nick-end labeling staining to identify the existence of diabetic cardiomyopathy and enhanced apoptosis in the diabetic heart. We performed immunohistochemistry, western blot, and real-time PCR to analyze the hallmarks of ERS that include glucose-regulated protein 78, CCAAT/enhancer-binding protein homologous protein (CHOP) and caspase12. We found these hallmarks to have enhanced expression in protein and mRNA levels in diabetic myocardium. Also, another pathway that can lead to cell death of ERS, c-Jun NH2-terminal kinase-dependent pathway, was also activated in diabetic heart. Those results suggested that ERS was induced in STZ-induced diabetic rats' myocardium, and ERS-associated apoptosis occurred in the pathophysiology of diabetic cardiomyopathy.
Search for other papers by Hong-Tao Zheng in
Google Scholar
PubMed
Search for other papers by Tao Fu in
Google Scholar
PubMed
Search for other papers by Hai-Yi Zhang in
Google Scholar
PubMed
Search for other papers by Zhen-Shan Yang in
Google Scholar
PubMed
Search for other papers by Zhan-Hong Zheng in
Google Scholar
PubMed
Search for other papers by Zeng-Ming Yang in
Google Scholar
PubMed
Glucocorticoids (GCs) are essential for mouse embryo implantation and decidualization. Excess GCs are harmful for mouse embryo implantation and decidualization. 11β-Hydroxysteroid dehydrogenases type I and II (Hsd11b1/Hsd11b2) are main enzymes for regulating local level of GCs. Hsd11b2 acts as the placental glucocorticoid barrier to protect the fetus from excessive exposure. Although effects of GCs on the fetus and placenta in late pregnancy have been extensively studied, the effects of these adrenal corticosteroids in early pregnancy are far less well defined. Therefore, we examined the expression, regulation and function of Hsd11b1/Hsd11b2 in mouse uterus during early pregnancy. We found that Hsd11b2 is highly expressed in endometrial stromal cells on days 3 and 4 of pregnancy and mainly upregulated by progesterone (P4). In both ovariectomized mice and cultured stromal cells, P4 significantly stimulates Hsd11b2 expression. P4 stimulation of Hsd11b2 is mainly mediated by the Ihh pathway. The uterine level of corticosterone (Cort) is regulated by Hsd11b2 during preimplantation. Embryo development and the number of inner cell mass cells are suppressed by Cort treatment. These results indicate that P4 should provide a low Cort environment for the development of preimplantation mouse embryos by promoting the expression of uterine Hsd11b2.
The Research Institute for Children, Departments of Pediatrics and Genetics, Children's Hospital, 200 Henry Clay Avenue, Research and Education Building, Room 2211, New Orleans, Louisiana 70118, USA
Search for other papers by Hong-Wei Wang in
Google Scholar
PubMed
Search for other papers by Michelle Muguira in
Google Scholar
PubMed
The Research Institute for Children, Departments of Pediatrics and Genetics, Children's Hospital, 200 Henry Clay Avenue, Research and Education Building, Room 2211, New Orleans, Louisiana 70118, USA
Search for other papers by Wei-Dong Liu in
Google Scholar
PubMed
The Research Institute for Children, Departments of Pediatrics and Genetics, Children's Hospital, 200 Henry Clay Avenue, Research and Education Building, Room 2211, New Orleans, Louisiana 70118, USA
Search for other papers by Tao Zhang in
Google Scholar
PubMed
Search for other papers by Chiachen Chen in
Google Scholar
PubMed
Search for other papers by Rebecca Aucoin in
Google Scholar
PubMed
The Research Institute for Children, Departments of Pediatrics and Genetics, Children's Hospital, 200 Henry Clay Avenue, Research and Education Building, Room 2211, New Orleans, Louisiana 70118, USA
Search for other papers by Mary B Breslin in
Google Scholar
PubMed
The Research Institute for Children, Departments of Pediatrics and Genetics, Children's Hospital, 200 Henry Clay Avenue, Research and Education Building, Room 2211, New Orleans, Louisiana 70118, USA
Search for other papers by Michael S Lan in
Google Scholar
PubMed
In this study, an insulinoma-associated antigen-1 (INSM1)-binding site in the proximal promoter sequence of the insulin gene was identified. The co-transfection of INSM1 with rat insulin I/II promoter-driven reporter genes exhibited a 40–50% inhibitory effect on the reporter activity. Mutational experiments were performed by introducing a substitution, GG to AT, into the INSM1 core binding site of the rat insulin I/II promoters. The mutated insulin promoter exhibited a three- to 20-fold increase in the promoter activity over the wild-type promoter in several insulinoma cell lines. Moreover, INSM1 overexpression exhibited no inhibitory effect on the mutated insulin promoter. Chromatin immunoprecipitation assays using βTC-1, mouse fetal pancreas, and Ad-INSM1-transduced human islets demonstrated that INSM1 occupies the endogenous insulin promoter sequence containing the INSM1-binding site in vivo. The binding of the INSM1 to the insulin promoter could suppress ∼50% of insulin message in human islets. The mechanism for transcriptional repression of the insulin gene by INSM1 is mediated through the recruitment of cyclin D1 and histone deacetylase-3 to the insulin promoter. Anti-INSM1 or anti-cyclin D1 morpholino treatment of fetal mouse pancreas enhances the insulin promoter activity. These data strongly support the view that INSM1 is a new zinc-finger transcription factor that modulates insulin gene transcription during early pancreas development.
East Carolina Diabetes and Obesity Institute, East Carolina University, Greenville, North Carolina, USA
Human Performance Laboratory, College of Health and Human Performance, East Carolina University, Greenville, North Carolina, USA
Search for other papers by Peixin Li in
Google Scholar
PubMed
Human Performance Laboratory, College of Health and Human Performance, East Carolina University, Greenville, North Carolina, USA
Department of Kinesiology, East Carolina University, Greenville, North Carolina, USA
Search for other papers by Zhijian Rao in
Google Scholar
PubMed
Human Performance Laboratory, College of Health and Human Performance, East Carolina University, Greenville, North Carolina, USA
Department of Kinesiology, East Carolina University, Greenville, North Carolina, USA
Search for other papers by Brenton Thomas Laing in
Google Scholar
PubMed
Human Performance Laboratory, College of Health and Human Performance, East Carolina University, Greenville, North Carolina, USA
Department of Kinesiology, East Carolina University, Greenville, North Carolina, USA
Search for other papers by Wyatt Bunner in
Google Scholar
PubMed
Human Performance Laboratory, College of Health and Human Performance, East Carolina University, Greenville, North Carolina, USA
Department of Kinesiology, East Carolina University, Greenville, North Carolina, USA
Search for other papers by Taylor Landry in
Google Scholar
PubMed
Search for other papers by Amber Prete in
Google Scholar
PubMed
Human Performance Laboratory, College of Health and Human Performance, East Carolina University, Greenville, North Carolina, USA
Search for other papers by Yuan Yuan in
Google Scholar
PubMed
Search for other papers by Zhong-Tao Zhang in
Google Scholar
PubMed
Human Performance Laboratory, College of Health and Human Performance, East Carolina University, Greenville, North Carolina, USA
Department of Kinesiology, East Carolina University, Greenville, North Carolina, USA
Department of Physiology, East Carolina University, Greenville, North Carolina, USA
Search for other papers by Hu Huang in
Google Scholar
PubMed
Vertical sleeve gastrectomy (VSG) is an effective surgery to treat obesity and diabetes. However, the direct effect of VSG on metabolic functions is not fully understood. We aimed to investigate if alterations in hypothalamic neurons were linked with perturbations in liver metabolism after VSG in an energy intake-controlled obese mouse model. C57BL/6 and hrNPY-GFP reporter mice received HFD for 12 weeks and were then divided into three groups: Sham (ad lib), Sham (pair-fed) with VSG and VSG. Food intake was measured daily, and blood glucose levels were measured before and after the study. Energy expenditure and body composition were determined. Serum parameters, liver lipid and glycogen contents were measured and gene/protein expression were analyzed. Hypothalamic POMC, AgRP/NPY and tyrosine hydroxylase-expressing neurons were counted. The following results were obtained. VSG reduced body weight gain and adiposity induced by HFD, increased energy expenditure independent of energy intake. Fed and fasted blood glucose levels were reduced in the VSG group. While serum active GLP-1 level was increased, the active ghrelin and triglycerides levels were decreased along with improved insulin resistance in VSG group. Liver lipid accumulation, glycogen content and gluconeogenic gene expression were reduced in the VSG group. In the hypothalamus, TH-expressing neuron population was decreased, and the POMC-expressing neuron population was increased in the VSG group. In conclusion, our data suggest that VSG improves metabolic symptoms by increasing energy expenditure and lowering lipid and glycogen contents in the liver. These physiological alterations are possibly related to changes in hypothalamic neuron populations.
Departments of Physiology,
Medicine and
Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Banting and Best Diabetes Center, Faculty of Medicine, University of Toronto, Ontario, Canada
Search for other papers by Yi Zhao in
Google Scholar
PubMed
Departments of Physiology,
Medicine and
Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Banting and Best Diabetes Center, Faculty of Medicine, University of Toronto, Ontario, Canada
Search for other papers by Tao Liu in
Google Scholar
PubMed
Departments of Physiology,
Medicine and
Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Banting and Best Diabetes Center, Faculty of Medicine, University of Toronto, Ontario, Canada
Search for other papers by Nina Zhang in
Google Scholar
PubMed
Departments of Physiology,
Medicine and
Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Banting and Best Diabetes Center, Faculty of Medicine, University of Toronto, Ontario, Canada
Search for other papers by Fenghua Yi in
Google Scholar
PubMed
Departments of Physiology,
Medicine and
Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Banting and Best Diabetes Center, Faculty of Medicine, University of Toronto, Ontario, Canada
Search for other papers by Qinghua Wang in
Google Scholar
PubMed
Departments of Physiology,
Medicine and
Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Banting and Best Diabetes Center, Faculty of Medicine, University of Toronto, Ontario, Canada
Search for other papers by Ivan George Fantus in
Google Scholar
PubMed
Departments of Physiology,
Medicine and
Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Banting and Best Diabetes Center, Faculty of Medicine, University of Toronto, Ontario, Canada
Search for other papers by Tianru Jin in
Google Scholar
PubMed
Although the homeobox gene Cdx-2 was initially isolated from the pancreatic β cell line HIT-T15, no examination of its role in regulating endogenous insulin gene expression has been reported. To explore further the role of Cdx-2 in regulating both insulin and proglucagon gene expression, we established an ecdysone-inducible Cdx-2 expression system. This report describes a study using the rat insulinoma cell line RIN-1056A, which abundantly expresses both insulin and proglucagon (glu), and relatively high amounts of endogenous Cdx-2. Following the introduction of the inducible Cdx-2 expression system into this cell line and the antibiotic selection procedure, we obtained novel cell lines that displayed dramatically reduced expression of endogenous Cdx-2, in the absence of the inducer. These novel cell lines did not express detectable amounts of glu mRNA or the glucagon hormone, while their insulin expression was not substantially affected. In the presence of the inducer, however, transfected Cdx-2 expression was dramatically increased, accompanied by stimulation of endogenous Cdx-2 expression. More importantly, activated Cdx-2 expression was accompanied by elevated insulin mRNA expression, and insulin synthesis. Cdx-2 bound to the insulin gene promoter enhancer elements, and stimulated the expression of a luciferase reporter gene driven by these enhancer elements. Furthermore, Cdx-2 and insulin gene expressions in the wild-type RIN-1056A cells were stimulated by forskolin treatment, and forskolin-mediated activation on insulin gene expression was attenuated in the absence of Cdx-2. We suggest that Cdx-2 may mediate the second messenger cAMP in regulating insulin gene transcription.
Search for other papers by Guofeng Zhang in
Google Scholar
PubMed
Search for other papers by Hiroki Hirai in
Google Scholar
PubMed
Search for other papers by Tao Cai in
Google Scholar
PubMed
Search for other papers by Junnosuke Miura in
Google Scholar
PubMed
Search for other papers by Ping Yu in
Google Scholar
PubMed
Search for other papers by Hanxia Huang in
Google Scholar
PubMed
Search for other papers by Martin R Schiller in
Google Scholar
PubMed
Search for other papers by William D Swaim in
Google Scholar
PubMed
Search for other papers by Richard D Leapman in
Google Scholar
PubMed
Search for other papers by Abner L Notkins in
Google Scholar
PubMed
The regulated endocrine-specific protein, RESP18, first found in the rat pituitary, was thought to be regulated by dopaminergic drugs. Bioinformatics studies showed that RESP18 shares sequence homology with the luminal region of IA-2, a dense core vesicle (DCV) transmembrane protein involved in insulin secretion. The present study was initiated to examine the genomic structure and subcellular localization of RESP18 and the effect of glucose on its expression. Human RESP18 was isolated from a pancreas cDNA library and its subcellular localization was determined by immunoelectron microscopy. MIN6 cells and mouse islets were used to study the effect of glucose on RESP18 expression. Bioinformatics analysis revealed that RESP18 and IA-2 are tandemly arranged within a 45 kb region on human chromosome 2 and share common intron–exon boundaries. By confocal microscopy, RESP18 was found in α, β and δ cells in the pancreatic islets. Electron microscopy revealed that RESP18 is present in the lumen of DCVs. The expression of RESP18 in β cells is markedly increased following exposure to high glucose and also elevated in the islets of diabetic, but not non-diabetic, NOD mice. We conclude that RESP18 is a luminal protein of DCVs and its expression is regulated by exposure to glucose.
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Search for other papers by Lei Du in
Google Scholar
PubMed
Search for other papers by Yang Wang in
Google Scholar
PubMed
Search for other papers by Cong-Rong Li in
Google Scholar
PubMed
Search for other papers by Liang-Jian Chen in
Google Scholar
PubMed
Search for other papers by Jin-Yang Cai in
Google Scholar
PubMed
Search for other papers by Zheng-Rong Xia in
Google Scholar
PubMed
Search for other papers by Wen-Tao Zeng in
Google Scholar
PubMed
Search for other papers by Zi-Bin Wang in
Google Scholar
PubMed
Search for other papers by Xi-Chen Chen in
Google Scholar
PubMed
Search for other papers by Fan Hu in
Google Scholar
PubMed
Animal Core Facility, Nanjing Medical University, Nanjing, Jiangsu, China
Search for other papers by Dong Zhang in
Google Scholar
PubMed
Search for other papers by Xiao-Wei Xing in
Google Scholar
PubMed
Search for other papers by Zhi-Xia Yang in
Google Scholar
PubMed
Polycystic ovarian syndrome (PCOS) is a major severe ovary disorder affecting 5–10% of reproductive women around the world. PCOS can be considered a metabolic disease because it is often accompanied by obesity and diabetes. Brown adipose tissue (BAT) contains abundant mitochondria and adipokines and has been proven to be effective for treating various metabolic diseases. Recently, allotransplanted BAT successfully recovered the ovarian function of PCOS rat. However, BAT allotransplantation could not be applied to human PCOS; the most potent BAT is from infants, so voluntary donors are almost inaccessible. We recently reported that single BAT xenotransplantation significantly prolonged the fertility of aging mice and did not cause obvious immunorejection. However, PCOS individuals have distinct physiologies from aging mice; thus, it remains essential to study whether xenotransplanted rat BAT can be used for treating PCOS mice. In this study, rat-to-mouse BAT xenotransplantation, fortunately, did not cause severe rejection reaction, and significantly recovered ovarian functions, indicated by the recovery of fertility, oocyte quality, and the levels of multiple essential genes and kinases. Besides, the blood biochemical index, glucose resistance, and insulin resistance were improved. Moreover, transcriptome analysis showed that the recovered PCOS F0 mother following BAT xenotransplantation could also benefit the F1 generation. Finally, BAT xenotransplantation corrected characteristic gene expression abnormalities found in the ovaries of human PCOS patients. These findings suggest that BAT xenotransplantation could be a novel therapeutic strategy for treating PCOS patients.
Search for other papers by Qiaoli Cui in
Google Scholar
PubMed
Search for other papers by Yijing Liao in
Google Scholar
PubMed
Search for other papers by Yaojing Jiang in
Google Scholar
PubMed
Search for other papers by Xiaohang Huang in
Google Scholar
PubMed
Search for other papers by Weihong Tao in
Google Scholar
PubMed
Search for other papers by Quanquan Zhou in
Google Scholar
PubMed
Search for other papers by Anna Shao in
Google Scholar
PubMed
Search for other papers by Ying Zhao in
Google Scholar
PubMed
Search for other papers by Jia Li in
Google Scholar
PubMed
Search for other papers by Anran Ma in
Google Scholar
PubMed
Search for other papers by Zhihong Wang in
Google Scholar
PubMed
Search for other papers by Li Zhang in
Google Scholar
PubMed
Search for other papers by Zunyuan Yang in
Google Scholar
PubMed
Search for other papers by Yinan Liang in
Google Scholar
PubMed
Search for other papers by Minglin Wu in
Google Scholar
PubMed
Search for other papers by Zhenyan Yang in
Google Scholar
PubMed
Search for other papers by Wen Zeng in
Google Scholar
PubMed
Shanghai Yinuo Pharmaceutical Co., Ltd., Shanghai, China
Keenan Research Centre for Biomedical Science, Division of Endocrinology and Metabolism, St. Michael’s Hospital, Toronto, Ontario, Canada
Search for other papers by Qinghua Wang in
Google Scholar
PubMed
Glucagon-like peptide 1 (GLP-1) is an insulinotropic hormone and plays an important role in regulating glucose homeostasis. GLP-1 has a short half-life (t1/2 < 2 min) due to degrading enzyme dipeptidyl peptidase-IV and rapid kidney clearance, which limits its clinical application as a therapeutic reagent. We demonstrated recently that supaglutide, a novel GLP-1 mimetic generated by recombinant fusion protein techniques, exerted hypoglycemic and β-cell trophic effects in type 2 diabetes db/db mice. In the present study, we examined supaglutide’s therapeutic efficacy and pharmacokinetics in diabetic rhesus monkeys. We found that a single subcutaneous injection of supaglutide of tested doses transiently and significantly reduced blood glucose levels in a dose-dependent fashion in the diabetic monkeys. During a 4-week intervention period, treatment of supaglutide of weekly dosing dose-dependently decreased fasting and random blood glucose levels. This was associated with significantly declined plasma fructosamine levels. The repeated administration of supaglutide remarkably also decreased body weight in a dose-dependent fashion accompanied by decreased food intake. Intravenous glucose tolerance test results showed that supaglutide improved glucose tolerance. The intervention also showed enhanced glucose-stimulated insulin secretion and improved lipid profile in diabetic rhesus monkeys. These results reveal that supaglutide exerts beneficial effects in regulating blood glucose and lipid homeostasis in diabetic rhesus monkeys.
Vascular Biology Center, Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia, USA
Search for other papers by Jiean Xu in
Google Scholar
PubMed
Vascular Biology Center, Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia, USA
Search for other papers by Qiuhua Yang in
Google Scholar
PubMed
Vascular Biology Center, Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia, USA
Search for other papers by Xiaoyu Zhang in
Google Scholar
PubMed
Vascular Biology Center, Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia, USA
Search for other papers by Zhiping Liu in
Google Scholar
PubMed
Vascular Biology Center, Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia, USA
Search for other papers by Yapeng Cao in
Google Scholar
PubMed
Vascular Biology Center, Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia, USA
Search for other papers by Lina Wang in
Google Scholar
PubMed
Vascular Biology Center, Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia, USA
Search for other papers by Yaqi Zhou in
Google Scholar
PubMed
Vascular Biology Center, Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia, USA
Search for other papers by Xianqiu Zeng in
Google Scholar
PubMed
Vascular Biology Center, Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia, USA
Search for other papers by Qian Ma in
Google Scholar
PubMed
School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China
Search for other papers by Yiming Xu in
Google Scholar
PubMed
College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
Search for other papers by Yong Wang in
Google Scholar
PubMed
Search for other papers by Lei Huang in
Google Scholar
PubMed
Search for other papers by Zhen Han in
Google Scholar
PubMed
Search for other papers by Tao Wang in
Google Scholar
PubMed
Search for other papers by David Stepp in
Google Scholar
PubMed
Search for other papers by Zsolt Bagi in
Google Scholar
PubMed
Search for other papers by Chaodong Wu in
Google Scholar
PubMed
Search for other papers by Mei Hong in
Google Scholar
PubMed
Search for other papers by Yuqing Huo in
Google Scholar
PubMed
Insulin resistance-related disorders are associated with endothelial dysfunction. Accumulating evidence has suggested a role for adenosine signaling in the regulation of endothelial function. Here, we identified a crucial role of endothelial adenosine kinase (ADK) in the regulation of insulin resistance. Feeding mice with a high-fat diet (HFD) markedly enhanced the expression of endothelial Adk. Ablation of endothelial Adk in HFD-fed mice improved glucose tolerance and insulin sensitivity and decreased hepatic steatosis, adipose inflammation and adiposity, which were associated with improved arteriole vasodilation, decreased inflammation and increased adipose angiogenesis. Mechanistically, ADK inhibition or knockdown in human umbilical vein endothelial cells (HUVECs) elevated intracellular adenosine level and increased endothelial nitric oxide synthase (NOS3) activity, resulting in an increase in nitric oxide (NO) production. Antagonism of adenosine receptor A2b abolished ADK-knockdown-enhanced NOS3 expression in HUVECs. Additionally, increased phosphorylation of NOS3 in ADK-knockdown HUVECs was regulated by an adenosine receptor-independent mechanism. These data suggest that Adk-deficiency-elevated intracellular adenosine in endothelial cells ameliorates diet-induced insulin resistance and metabolic disorders, and this is associated with an enhancement of NO production caused by increased NOS3 expression and activation. Therefore, ADK is a potential target for the prevention and treatment of metabolic disorders associated with insulin resistance.
